ImmuCell Corporation Increase (Decrease) in Deferred Revenue
ImmuCell Corporation (ICCC) reported Increase (Decrease) in Deferred Revenue of -$24.10 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2020-03-27
- ImmuCell Corporation increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $24.10K.
- ImmuCell Corporation increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was $0.00.
- ImmuCell Corporation increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was -$33.86K.
- ImmuCell Corporation increase (decrease) in deferred revenue for fiscal 2018 was -$24.10K.
- ImmuCell Corporation increase (decrease) in deferred revenue for fiscal 2017 was -$9.76K, a 128.82% decline from fiscal 2016.
- ImmuCell Corporation increase (decrease) in deferred revenue for fiscal 2016 was $33.86K.
- ImmuCell Corporation increase (decrease) in deferred revenue for fiscal 2015 was -$6.69K, a 200.00% decline from fiscal 2014.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$24.10K 10-K · filed 2020-03-27 | |||
| 2017-12-31 | $24.10K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $24.10K derived: sum of 2 quarters · filed 2019-03-22 | $24.10K derived: sum of 3 quarters · filed 2019-03-22 | -$9.76K 10-K · filed 2019-03-22 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | -$33.86K 10-Q · filed 2018-11-13 | -$33.86K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$33.86K 10-Q · filed 2018-08-13 | -$33.86K derived: sum of 3 quarters · filed 2018-08-13 | $0.00 derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | -$33.86K 10-Q · filed 2018-05-14 | -$33.86K derived: sum of 2 quarters · filed 2018-05-14 | $0.00 derived: sum of 3 quarters · filed 2018-05-14 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $33.86K derived: sum of 2 quarters · filed 2018-03-29 | $33.86K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $33.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $33.86K 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $0.00 derived: sum of 2 quarters · filed 2017-03-30 | -$6.69K 10-K · filed 2017-03-30 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$6.69K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$6.69K 10-Q · filed 2016-08-11 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $6.69K derived: sum of 2 quarters · filed 2016-03-25 | $6.69K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $6.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $6.69K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-13 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$250.00K derived: sum of 2 quarters · filed 2016-03-25 | $0.00 10-K · filed 2016-03-25 | |
| 2013-09-30 | -$250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | $250.00K 10-Q · filed 2014-08-13 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $0.00 derived: sum of 2 quarters · filed 2015-03-26 | -$8.25K derived: sum of 3 quarters · filed 2015-03-26 | -$8.25K 10-K · filed 2015-03-26 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$8.25K derived: sum of 2 quarters · filed 2013-11-13 | -$8.25K 10-Q · filed 2013-11-13 | -$8.25K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-06-30 | -$8.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$8.25K 10-Q · filed 2013-08-13 | -$8.25K derived: sum of 3 quarters · filed 2014-03-26 | -$8.25K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-03-26 | $0.00 derived: sum of 3 quarters · filed 2014-03-26 | $0.00 derived: sum of 4 quarters · filed 2014-03-26 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $0.00 derived: sum of 2 quarters · filed 2014-03-26 | $0.00 derived: sum of 3 quarters · filed 2014-03-26 | $8.25K 10-K · filed 2014-03-26 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $8.25K 10-Q · filed 2012-11-13 | $8.25K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-07 | $8.25K 10-Q/A · filed 2012-09-07 | $8.25K derived: sum of 3 quarters · filed 2013-03-28 | $8.25K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-03-31 | $8.25K 10-Q · filed 2012-05-14 | $8.25K derived: sum of 2 quarters · filed 2013-03-28 | $8.25K derived: sum of 3 quarters · filed 2013-03-28 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $0.00 derived: sum of 2 quarters · filed 2013-03-28 | $0.00 10-K · filed 2013-03-28 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 | |||
| 2009-12-31 | $0.00 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |